Overview
Ruo-hong Shui practices practicing medicine in Shanghai, China.
Their clinical expertise encompasses Fibrocystic Breast Disease, Breast Cancer, Anaplastic Large Cell Lymphoma, and T-Cell Lymphoma.
They are actively involved in clinical research, co-authoring 12 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ruo-hong Shui
Is Ruo-hong Shui a top-rated expert for Fibrocystic Breast Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Ruo-hong Shui is classified as an Experienced expert for Fibrocystic Breast Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ruo-hong Shui participate in research or clinical trials?
Yes. Ruo-hong Shui has published 12 articles and abstracts on conditions like Fibrocystic Breast Disease. You can view a list of Ruo-hong Shui's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Anaplastic Large Cell Lymphoma
- Breast CancerShui isExperienced. Learn about Breast Cancer.
- Fibrocystic Breast DiseaseShui isExperienced. Learn about Fibrocystic Breast Disease.
- T-Cell LymphomaShui isExperienced. Learn about T-Cell Lymphoma.